Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liam R Brunham

Showing results (81-90 of 156) with videos related to

Pageof 16
Sort By:
The Pharmacogenomics Journal|September 26, 2018
Economic burden of adverse drug reactions and potential for pharmacogenomic testing in Singaporean adultsSze Ling Chan, Hong Yen Ng, Cynthia Sung, et al.
Journal of Clinical Lipidology|April 1, 2023
Metabolic syndrome predicts cardiovascular risk and mortality in familial hypercholesterolemiaMartine Paquette, Sophie Bernard, Bertrand Cariou, et al.
JACC. Advances|January 15, 2025
Preventive Lipid-Lowering Therapy and Interactions With Health Care in Patients Who Develop Premature Coronary Artery DiseaseDiana N Vikulova, May Kuen Lee, Karin H Humphries, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 26, 2021
Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial HypercholesterolemiaMartine Paquette, Sophie Bernard, Bertrand Cariou, et al.
The Canadian Journal of Cardiology|July 31, 2018
Attainment of Recommended Lipid Targets in Patients With Familial Hypercholesterolemia: Real-World Experience With PCSK9 InhibitorsOmar Razek, Lubormira Cermakova, Hamidreza Armani, et al.
CJC Open|March 12, 2020
Priorities for Services in Young Patients With Atherosclerotic Cardiovascular Disease and Their Family Members: An Exploratory Mixed-Methods StudyRaymond Y Cho, Jian Weng, Kelsey Lynch, et al.
European Journal of Preventive Cardiology|June 13, 2025
Rationale for the Routine Screening of Lipoprotein (a) in Cardiovascular Risk AssessmentIulia Iatan, Marlys L Koschinsky, Logan Trenaman, et al.
JAMA Cardiology|September 14, 2022
Burden of Rare Genetic Variants in Spontaneous Coronary Artery Dissection With High-risk FeaturesYu Wang, Andrew Starovoytov, Andrea M Murad, et al.
British Journal of Clinical Pharmacology|September 20, 2016
Prevalence and characteristics of adverse drug reactions at admission to hospital: a prospective observational studySze Ling Chan, Xiaohui Ang, Levana L Sani, et al.
European Journal of Preventive Cardiology|September 1, 2022
Effect of the LDL receptor mutation type on incident major adverse cardiovascular events in familial hypercholesterolaemiaMartine Paquette, Alain Carrié, Sophie Bernard, et al.
Pageof 16

Showing results (81-90 of 156) with videos related to

Sort By:
Pageof 16
The Pharmacogenomics Journal|September 26, 2018
Economic burden of adverse drug reactions and potential for pharmacogenomic testing in Singaporean adultsSze Ling Chan, Hong Yen Ng, Cynthia Sung, et al.
Journal of Clinical Lipidology|April 1, 2023
Metabolic syndrome predicts cardiovascular risk and mortality in familial hypercholesterolemiaMartine Paquette, Sophie Bernard, Bertrand Cariou, et al.
JACC. Advances|January 15, 2025
Preventive Lipid-Lowering Therapy and Interactions With Health Care in Patients Who Develop Premature Coronary Artery DiseaseDiana N Vikulova, May Kuen Lee, Karin H Humphries, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 26, 2021
Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial HypercholesterolemiaMartine Paquette, Sophie Bernard, Bertrand Cariou, et al.
The Canadian Journal of Cardiology|July 31, 2018
Attainment of Recommended Lipid Targets in Patients With Familial Hypercholesterolemia: Real-World Experience With PCSK9 InhibitorsOmar Razek, Lubormira Cermakova, Hamidreza Armani, et al.
CJC Open|March 12, 2020
Priorities for Services in Young Patients With Atherosclerotic Cardiovascular Disease and Their Family Members: An Exploratory Mixed-Methods StudyRaymond Y Cho, Jian Weng, Kelsey Lynch, et al.
European Journal of Preventive Cardiology|June 13, 2025
Rationale for the Routine Screening of Lipoprotein (a) in Cardiovascular Risk AssessmentIulia Iatan, Marlys L Koschinsky, Logan Trenaman, et al.
JAMA Cardiology|September 14, 2022
Burden of Rare Genetic Variants in Spontaneous Coronary Artery Dissection With High-risk FeaturesYu Wang, Andrew Starovoytov, Andrea M Murad, et al.
British Journal of Clinical Pharmacology|September 20, 2016
Prevalence and characteristics of adverse drug reactions at admission to hospital: a prospective observational studySze Ling Chan, Xiaohui Ang, Levana L Sani, et al.
European Journal of Preventive Cardiology|September 1, 2022
Effect of the LDL receptor mutation type on incident major adverse cardiovascular events in familial hypercholesterolaemiaMartine Paquette, Alain Carrié, Sophie Bernard, et al.
Pageof 16